Staying on message: design principles for controlling nonspecific responses to siRNA

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The FEBS Journal

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1742-4658.2010.07905.xPMID 21078117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Designing highly active siRNAs for therapeutic applications

  2010cited by this paper
• Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

  2010cited by this paper
• Efficient and targeted delivery of siRNA in vivo

  2010cited by this paper
• Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus.

  2009cited by this paper
• 2'-5'-Oligoadenylate synthetase is activated by a specific RNA sequence motif.

  2009cited by this paper
• Pathogen recognition in the innate immune response.

  2009cited by this paper
• Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth

  2009cited by this paper
• The promises and pitfalls of RNA-interference-based therapeutics

  2009cited by this paper
• Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation

  2008cited by this paper
• TLR7 Is Involved in Sequence-Specific Sensing of Single-Stranded RNAs in Human Macrophages1

  2008cited by this paper
• Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA

  2008cited by this paper
• Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses1

  2008cited by this paper
• Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

  2008cited by this paper
• The TLR3 signaling complex forms by cooperative receptor dimerization

  2008cited by this paper
• A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation

  2008cited by this paper
• 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma

  2008cited by this paper
• 2'-O-methyl-modified RNAs act as TLR7 antagonists.

  2007cited by this paper
• Small self-RNA generated by RNase L amplifies antiviral innate immunity

  2007cited by this paper
• A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells

  2006cited by this paper
• Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

  2006cited by this paper
• Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides

  2006cited by this paper
• Cleavage of the siRNA passenger strand during RISC assembly in human cells

  2006cited by this paper
• Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo.

  2006cited by this paper
• 5'-Triphosphate RNA Is the Ligand for RIG-I

  2006cited by this paper
• siRNA binding proteins of microglial cells: PKR is an unanticipated ligand

  2006cited by this paper
• Single‐stranded small interfering RNA are more immunostimulatory than their double‐stranded counterparts: A central role for 2′‐hydroxyl uridines in immune responses

  2006cited by this paper
• Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

  2005cited by this paper
• Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.

  2005cited by this paper
• Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction

  2005cited by this paper
• Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

  2005cited by this paper
• Recognition of Double-stranded RNA by Human Toll-like Receptor 3 and Downstream Receptor Signaling Requires Multimerization and an Acidic pH*

  2005cited by this paper
• Production of type I interferons

  2005cited by this paper
• Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7

  2005cited by this paper
• Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

  2005cited by this paper
• Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8

  2005cited by this paper
• Positional effect of chemical modifications on short interference RNA activity in mammalian cells.

  2005cited by this paper
• Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization.

  2005cited by this paper
• In vivo activity of nuclease-resistant siRNAs.

  2004cited by this paper
• Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8

  2004cited by this paper
• The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.

  2004cited by this paper
• Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase

  2004cited by this paper
• Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

  2004cited by this paper
• Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells.

  2004cited by this paper
• Toll-like receptor control of the adaptive immune responses

  2004cited by this paper
• Small Interfering RNAs Mediate Sequence-Independent Gene Suppression and Induce Immune Activation by Signaling through Toll-Like Receptor 31

  2004cited by this paper
• Activation of the interferon system by short-interfering RNAs

  2003cited by this paper
• Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway

  2003cited by this paper
• Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells.

  2003cited by this paper
• siRNA function in RNAi: a chemical modification analysis.

  2003cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Signal Integration via PKR

  2001cited by this paper
• Specific interference with gene function by double-stranded RNA in early mouse development

  2000cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper
• Interactions between double-stranded RNA regulators and the protein kinase DAI

  1992cited by this paper
• Metabolic stability of 2' 5'oligo (A) and activity of 2' 5'oligo (A)-dependent endonuclease in extracts of interferon-treated and control HeLa cells.

  1979cited by this paper
• Inducers of interferon and host resistance. I. Double-stranded RNA from extracts of Penicillium funiculosum.

  1967cited by this paper

• Emerging nanocarrier platforms in cervical cancer therapy: From molecular targeting to precision nanomedicine.

  2026cites this paper
• Inactivity-induced phrenic motor facilitation requires PKCζ activity within phrenic motor neurons.

  2024cites this paper
• siRNA containing a unique 5-nucleotide motif acts as a quencher of IFI16-mediated innate immune response

  2019cites this paper
• In silico prediction of short hairpin RNA and in vitro silencing of activin receptor type IIB in chicken embryo fibroblasts by RNA interference

  2019cites this paper
• Cyclin B1 knockdown mediated by clinically approved pulsed electric fields siRNA delivery induces tumor regression in murine melanoma.

  2019cites this paper
• Applications of RNA interference in the treatment of arthritis.

  2019cites this paper
• Controlling miRNA-like off-target effects of an siRNA with nucleobase modifications.

  2017cites this paper
• siRNA Therapeutics to Treat Liver Disorders

  2017cites this paper
• Intramyocardial Gene Silencing by Interfering RNA

  2017cites this paper
• Apoptotic Effect of Specific siRNA against HMGA2 on PC3 Prostate Adenocarcinoma Cell Line

  2016cites this paper
• N-ethylmaleimide-sensitive factor siRNA inhibits the release of Weibel-Palade bodies in endothelial cells

  2016cites this paper
• Lipid nanoparticles as non-viral vectors for siRNA delivery

  2016cites this paper
• Effects of siRNA-squalene nanoparticles on RET/PTCs junction oncogenes in papillary thyroid carcinoma : from molecular and cellular studies to preclinical investigations

  2014cites this paper
• High-throughput siRNA Screen in Dendritic Cells to Discover New Genes Regulating Immunologic Tolerance

  2014cites this paper
• Effectiveness of local injection of lentivirus‐delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse

  2014cites this paper
• Fetal brain mTOR signaling activation in tuberous sclerosis complex.

  2014cites this paper
• RNA based antisense drugs: different types, molecular mechanisms and clinical trials

  2014cites this paper
• Targeting noncoding RNA for treatment of autism spectrum disorders

  2014cites this paper
• Strategies for in vivo targeted gene silencing

  2013cites this paper
• Advances in siRNA delivery to T-cells: potential clinical applications for inflammatory disease, cancer and infection.

  2013cites this paper
• Design of siRNA Therapeutics from the Molecular Scale

  2013influential citation
• Western blot evaluation of siRNA delivery by pH-responsive peptides.

  2013cites this paper
• Lentiviral-mediated gene transfer of siRNAs for the treatment of Huntington's disease.

  2013cites this paper
• iPSC-based Cardiovascular Disease Modeling : From Patient to 384-Well Plate

  2013cites this paper
• Challenges and Opportunities in Bringing RNAi Technologies from Bench to Bed

  2013cites this paper
• Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery

  2013cites this paper
• Synthesis of internal amide bond short interfering RNAs (siRNAs) and investigation of their gene silencing properties

  2013cites this paper
• Polymeric Micelles for siRNA Delivery

  2013cites this paper
• Review article. Strategies for in vivo targeted gene silencing

  2013cites this paper
• Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery

  2013cites this paper
• Marek’s disease virus pathogenesis and latency

  2012cites this paper
• Mini-clusters with mean probabilities for identifying effective siRNAs

  2012cites this paper
• Development of a 2′,4′-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo

  2012cites this paper
• Selective targeting of cancer cells with RNA aptamers

  2012cites this paper
• RNA-based therapeutics: current progress and future prospects.

  2012cites this paper
• The role of TSC2 and deptor in fetal cortical development

  2012cites this paper
• siRNA Therapeutic Design: Tools and Challenges

  2012cites this paper
• Before and after endosomal escape: roles of stimuli-converting siRNA/polymer interactions in determining gene silencing efficiency.

  2012cites this paper
• Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers

  2012influential citation
• Selecting highly effective siRNAs by their modified entropies with mini-clusters

  2012cites this paper
• siRNA as a conventional drug in the clinic? Challenges and current technologies.

  2012cites this paper
• Antiviral RNAi: Translating Science Towards Therapeutic Success

  2011cites this paper
• To Be Targeted: Is the Magic Bullet Concept a Viable Option for Synthetic Nucleic Acid Therapeutics?

  2011cites this paper
• Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.

  2011cites this paper
• Efficient and targeted delivery of siRNA in vivo

  2010cites this paper
• Designing highly active siRNAs for therapeutic applications

  2010cites this paper